UDG Healthcare Public Limited Co. Update disclosure of relevant securities in issue (4567C)
19 June 2021 - 2:54AM
UK Regulatory
TIDMUDG
RNS Number : 4567C
UDG Healthcare Public Limited Co.
18 June 2021
UDG HEALTHCARE PLC
Update disclosure of relevant securities in issue pursuant to
Takeover Rule 2.10
18 June, 2021
In accordance with Rule 2.10 of the Irish Takeover Panel Act,
1997 Takeover Rules, 2013 ("Takeover Rules"), UDG confirms that it
has 251,974,223 ordinary shares of EUR0.05 each ("UDG Ordinary
Shares") in issue and admitted to listing on the Official List of
the Financial Conduct Authority and to trading on the main market
of the London Stock Exchange. This reflects an increase of 43,705
as against the number disclosed on 1 June, 2021 pursuant to Rule
2.10. The ISIN for the UDG Ordinary Shares is IE0033024807.
UDG also confirms that there are 3,270,392 options over ordinary
shares outstanding under the Company's share schemes (the 2010 Long
Term Incentive Plan and the 2019 Performance Share Plan). This
reflects a reduction of 43,705 as against the number disclosed on 1
June, 2021 pursuant to Takeover Rule 2.10.
Contact
Damien Moynagh
General Counsel & Company Secretary
Tel: + 353-1-468-9000
The directors of UDG ("UDG Directors") accept responsibility for
the information contained in this announcement. To the best of the
knowledge and belief of the UDG Directors (who have taken all
reasonable care to ensure such is the case), the information
contained in this announcement is in accordance with the facts and
does not omit anything likely to affect the import of such
information.
This announcement is not intended to, and does not, constitute
or form part of any offer, invitation or the solicitation of an
offer to purchase, otherwise acquire, subscribe for, sell or
otherwise dispose of, any securities whether pursuant to this
announcement or otherwise. The distribution of this announcement in
jurisdictions outside Ireland or the United Kingdom may be
restricted by law and therefore persons into whose possession this
announcement comes should inform themselves about, and observe,
such restrictions. Any failure to comply with the restrictions may
constitute a violation of the securities law of any such
jurisdiction.
Any holder of 1% or more of any class of relevant securities of
UDG may have disclosure obligations under Rule 8.3 of the Takeover
Rules effective from 12 May, 2021, the date of the commencement of
the offer period for UDG under the Takeover Rules.
Information in relation to relevant securities in this
announcement is as of the close of business on 17 June 2021.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCKZGMVVRZGMZM
(END) Dow Jones Newswires
June 18, 2021 12:54 ET (16:54 GMT)
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Apr 2024 to May 2024
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From May 2023 to May 2024